Health ❯ Healthcare ❯ Obesity ❯ Treatment Options

Deprescription Strategies

WHO Elevates GLP-1 Drugs to Essential Medicines as Cardio Data Build and Coverage Battles Escalate

WHO says generic competition is needed to make the drugs affordable globally.

ESC Data Tie Wegovy and Mounjaro to Lower HFpEF Hospitalization and Death, With Novo Citing CV Edge for Wegovy